iTeos Therapeutics (ITOS) IPO Opens 34% Higher

Today's IPO for iTeos Therapeutics, Inc. (NASDAQ: ITOS) opened for trading at $25.55 after pricing 10,586,316 shares of common stock at a public offering price of $19.00 per share.

In addition, iTeos has granted the underwriters a 30-day option to purchase up to an additional 1,587,947 shares of common stock at the initial public offering price, less underwriting discounts and commissions.

J.P. Morgan, SVB Leerink and Piper Sandler & Co. are acting as joint book-running managers for the offering. Wedbush PacGrow is acting as lead manager for the offering.

iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients.

You May Also Be Interested In

• Holtec Nuclear Corporation files for initial public offering
• Columbus Circle Capital Corp. III closes $230M IPO on Nasdaq
• Apnimed files for initial public offering on Nasdaq